according to bloomberg , eli lilly co 's third quarter profit rose percent as sales of its cymbalta antidepressant almost doubled net income rose to million , or cents a share , from million , or cents , a year earlier , the company said in a statement on pr newswire the result beat analyst estimates revenue from cymbalta , up percent to million , benefited after lilly reorganized its sales force to focus on the market for depression drugs cymbalta continues to show exceptionally strong growth in , and new prescription levels are currently more than percent above late levels , '' ryan wrote in an oct report to investors lilly also said that sales of the zyprexa schizophrenia drug , which declined percent in , had stabilized sales of zyprexa rose percent to billion , the first increase recorded for the drug in at least six quarters in , the drug provided about percent of the company 's total sales zyprexa benefited from pricing increases that are offsetting double digit prescription declines , '' said chris shibutani , a jp morgan securities analyst in new york , in an oct report to investors in july , the state of mississippi joined three other states suing lilly over zyprexa , saying the drugmaker fraudulently touted zyprexa for unapproved uses , including for children , and hid the drug 's potential hazards , including excessive weight gain and an increased risk of diabetes lilly has agreed to settle about , personal injury complaints related to the drug for million in and faces more than , additional claims must be all that evidence piling up indicating that cymbalta is much more safe and effective than other antidepressants ? perhaps i should post on the evidence regarding this hot selling medication i can see why lilly keeps jacking up the price of zyprexa with all of the lawsuits , it has to be pretty pricey to justify its existence ! link to bloomberg article here